These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27222073)

  • 21. Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.
    Yang Y; Zhou X; Gao S; Lin H; Xie Y; Feng Y; Huang K; Zhan S
    Drug Saf; 2018 Jan; 41(1):125-137. PubMed ID: 28815480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database.
    Mott K; Graham DJ; Toh S; Gagne JJ; Levenson M; Ma Y; Reichman ME
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1023-32. PubMed ID: 27146123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoepidemiology and Drug Safety's special issue on validation studies.
    Chun DS; Lund JL; Stürmer T
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):123-125. PubMed ID: 30714240
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacoepidemiological research with large health databases].
    Andersohn F; Garbe E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1135-44. PubMed ID: 18985407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.
    Lin KJ; Schneeweiss S
    Clin Pharmacol Ther; 2016 Aug; 100(2):147-59. PubMed ID: 26916672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of a self-controlled case series study to a database study in children.
    Ueyama H; Hinotsu S; Tanaka S; Urushihara H; Nakamura M; Nakamura Y; Kawakami K
    Drug Saf; 2014 Apr; 37(4):259-68. PubMed ID: 24652448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
    Robb MA; Racoosin JA; Sherman RE; Gross TP; Ball R; Reichman ME; Midthun K; Woodcock J
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():9-11. PubMed ID: 22262587
    [No Abstract]   [Full Text] [Related]  

  • 29. Developing alerting thresholds for prospective drug safety monitoring.
    Wangge G; Schneeweiss S; Glynn RJ; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):755-62. PubMed ID: 26596260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs.
    Larsen MD; Cars T; Hallas J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):13-8. PubMed ID: 22901097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Good Signal Detection Practices: Evidence from IMI PROTECT.
    Wisniewski AF; Bate A; Bousquet C; Brueckner A; Candore G; Juhlin K; Macia-Martinez MA; Manlik K; Quarcoo N; Seabroke S; Slattery J; Southworth H; Thakrar B; Tregunno P; Van Holle L; Kayser M; Norén GN
    Drug Saf; 2016 Jun; 39(6):469-90. PubMed ID: 26951233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverging approaches of pharmacovigilance and pharmacoepidemiology to assessing drug safety: epistemological and ethical implications.
    Coste J
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):600-602. PubMed ID: 28239922
    [No Abstract]   [Full Text] [Related]  

  • 33. Methods for safety signal detection in healthcare databases: a literature review.
    Arnaud M; Bégaud B; Thurin N; Moore N; Pariente A; Salvo F
    Expert Opin Drug Saf; 2017 Jun; 16(6):721-732. PubMed ID: 28490262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
    Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From pharmacovigilance to pharmacoepidemiology and risk coordination].
    Montastruc JL
    Rev Med Interne; 2009 Dec; 30 Suppl 4():S281-90. PubMed ID: 19892443
    [No Abstract]   [Full Text] [Related]  

  • 36. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs.
    Lapeyre-Mestre M; Montastruc F
    Therapie; 2019 Apr; 74(2):209-214. PubMed ID: 30792079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IMI PROTECT project: purpose, organizational structure, and procedures.
    Reynolds RF; Kurz X; de Groot MC; Schlienger RG; Grimaldi-Bensouda L; Tcherny-Lessenot S; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():5-10. PubMed ID: 27038353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
    Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
    Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.